HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2- (4- hydroxy- 3- methoxyphenyl)benzothiazole

induces CHIP protein expression; has antineoplastic activity; structure in first source

Also Known As:

YL-109

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Goto, Natsuka: 1 article (11/2014)
2.	Hirata, Naoya: 1 article (11/2014)
3.	Hiyoshi, Hiromi: 1 article (11/2014)
4.	Iida, Keisuke: 1 article (11/2014)
5.	Kanda, Yasunari: 1 article (11/2014)
6.	Nagasawa, Kazuo: 1 article (11/2014)
7.	Nakajima, Yuka: 1 article (11/2014)
8.	Tsuchiya, Mai: 1 article (11/2014)
9.	Yanagisawa, Junn: 1 article (11/2014)

Related Diseases

1.	Endometriosis 12/19/2022 - "Furthermore, the CHIP agonist YL-109 effectively suppresses the growth of ectopic endometrium in endometriosis mouse model, which could be a potential therapeutic approach for endometriosis. "
2.	Breast Neoplasms (Breast Cancer) 11/18/2014 - "It suggests that YL-109 is a potential candidate for breast cancer therapy. " 11/18/2014 - "YL-109 increased the expression of carboxyl terminus of Hsp70-interacting protein (CHIP), which suppresses tumorigenic and metastatic potential of breast cancer cells by inhibiting the oncogenic pathway. "

Related Drugs and Biologics

1.	Proteins (Proteins, Gene)

Related Therapies and Procedures

1.	Therapeutics